Literature DB >> 11155845

From clinical recommendations to mandatory practice. The introduction of regulatory practice guidelines in the French healthcare system.

P Durieux1, C Chaix-Couturier, I Durand-Zaleski, P Ravaud.   

Abstract

In an effort to control ambulatory care costs, regulatory practice guidelines (références médicales opposables or RMOs) were introduced by law in France in 1993. RMOs are short sentences, negatively formulated ("it is inappropriate to..."), covering medical and surgical topics, diagnosis, and treatment. Since their introduction, physicians who do not comply with RMOs can be fined. The fine is determined by a weighted combination of indices of harm, cost, and the number of violations. The impact of the RMO policy on physician practice has been questioned, but so far few evaluations had been performed. At the end of 1997, only 121 physicians had been fined (0.1% of French private physicians). The difficulty of controlling physicians, the large number of RMOs, and the lack of a relevant information system limit the credibility of this policy. The simultaneous development of a clinical guideline program to improve the quality of care and of a program to control medical practice can lead to a misunderstanding among clinicians and health policy makers. Financial incentives or disincentives could be used to change physician behavior, in addition to other measures such as education and organizational changes, if they are simple, well explained, and do not raise any ethical conflict. But these measures are dependent on the structure and financing of the healthcare system and on the socioeconomic and cultural context. More research is needed to assess the impact of interventions using financial incentives and disincentives on physician behavior.

Mesh:

Year:  2000        PMID: 11155845     DOI: 10.1017/s0266462300103046

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  The health care system under French national health insurance: lessons for health reform in the United States.

Authors:  Victor G Rodwin
Journal:  Am J Public Health       Date:  2003-01       Impact factor: 9.308

Review 2.  A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Authors:  Lianne Barnieh; Fiona Clement; Anthony Harris; Marja Blom; Cam Donaldson; Scott Klarenbach; Don Husereau; Diane Lorenzetti; Braden Manns
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

3.  Prescriber variation in potentially inappropriate prescribing in older populations in Ireland.

Authors:  Caitriona Cahir; Tom Fahey; Conor Teljeur; Kathleen Bennett
Journal:  BMC Fam Pract       Date:  2014-04-02       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.